GME vs KALA · P/E 16, rev $3.63B vs $54.3M cap
GameStop Corp. (GME) versus Kala Pharmaceuticals Inc (KALA) — a side-by-side from cached financials, not a winner call.
GameStop Corp. (GME) is a specialty retail company listed on US. It is led by Ryan Cohen.
Kala Pharmaceuticals Inc (KALA) is a biotechnology company listed on NASDAQ.
Latest reported GME revenue for 2026-01-31 was $3.63B. Net income was $418.4M. Revenue was down 5.1% from 2025-02-01 to 2026-01-31. GME currently screens at market cap $9.78B and trailing P/E 16.3.
Latest reported KALA revenue for 2025-12-31 was $0. Net income was -$27.0M. KALA currently screens at market cap $54.3M.
GME currently screens at market cap $9.78B and trailing P/E 16.3. KALA currently screens at market cap $54.3M.
Not investment advice. Open the GME and KALA stock pages for the full models.
Not investment advice.